Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy

It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma

(2017) Elena Elimova et al.   JOURNAL OF CLINICAL ONCOLOGY

Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer

(2016) Naruhiko Ikoma et al.   ANNALS OF SURGICAL ONCOLOGY

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma

(2016) Nikolaos Charalampakis et al.   ANNALS OF SURGICAL ONCOLOGY

Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer

(2016) Naruhiko Ikoma et al.   ANNALS OF SURGICAL ONCOLOGY

Japanese gastric cancer treatment guidelines 2014 (ver. 4)

(2016)   Gastric Cancer

Survival rates in T1 and T2 gastric cancer: A Western report

(2016) Naruhiko Ikoma et al.   JOURNAL OF SURGICAL ONCOLOGY

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

(2016) Salah-Eddin Al-Batran et al.   LANCET ONCOLOGY

Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy

(2015) Brian Badgwell et al.   ANNALS OF SURGICAL ONCOLOGY

TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)

(2015) Trevor Leong et al.   BMC CANCER

Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses

(2015) Se Hoon Park et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenocarcinoma undergoing gastrectomy

(2015) Deep Pujara et al.   JOURNAL OF SURGICAL ONCOLOGY

Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy

(2015) Brian Badgwell et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study

(2014) Olivier Glehen et al.   BMC CANCER

Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

(2014) T. Waddell et al.   EJSO

Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer

(2013) M. Degiuli et al.   BRITISH JOURNAL OF SURGERY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for the management of oesophageal and gastric cancer

(2011) W. H. Allum et al.   GUT

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

(2011) Mitsuru Sasako et al.   JOURNAL OF CLINICAL ONCOLOGY

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

S3-Leitlinie „Magenkarzinom” -

(2011) M. Moehler et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE